![]() |
|
|
Departments of Medicine and Chemistry, University of Vermont, Burlington, VT 05405
3To whom correspondence should be addressed. E-mail: Dwight.Matthews{at}uvm.edu.
Since the in vitro study of Buse and Reid in 1975 showing a stimulatory effect of leucine upon rat muscle protein synthesis and reduction in proteolysis, a similar effect has been sought in humans. In 1978, Sherwin demonstrated in humans an improvement in N balance with infusion of leucine in obese subjects fasting to lose weight. A variety of subsequent studies have been performed in humans where leucine alone or the BCAAs have been administered in varying amounts and durations, and the effect upon protein metabolism has been measured. Measurements of changes in muscle amino acid metabolism were made by arteriovenous difference measurements and by biopsies. An anabolic effect of leucine and the branched-chain amino acids (BCAAs) on reduction of muscle protein breakdown was found in these studies, with no measured effect upon muscle protein synthesis. Later studies using stable isotope tracers to define both whole-body protein turnover and leg or arm protein metabolism have similarly concluded that leucine administration specifically induces a reduction in protein breakdown without increasing protein synthesis. This anabolic effect, produced through a reduction of protein breakdown in vivo in humans by leucine is contrary to in vitro studies of rat muscle where stimulation of protein synthesis, has been demonstrated by leucine. Likewise an increase in protein synthesis has also been demonstrated by insulin in rat muscle that is not seen in humans. Of the various studies administering BCAAs or leucine to humans for varying periods of time and amount, the results have been consistent. In addition, no untoward effects have been reported in any of these studies from infusion of the BCAAs at upward 3 times basal flux or 6 times normal dietary intake during the fed portion of the day.
KEY WORDS: protein synthesis protein breakdown leucine
This article has been cited by other articles:
![]() |
S. Verhoeven, K. Vanschoonbeek, L. B Verdijk, R. Koopman, W. K. Wodzig, P. Dendale, and L. J. van Loon Long-term leucine supplementation does not increase muscle mass or strength in healthy elderly men Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1468 - 1475. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Frost, G. J. Nystrom, L. S. Jefferson, and C. H. Lang Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E501 - E512. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W-C. Hsu, W. Kriengsinyos, L. J. Wykes, M. Rafii, L. A. Goonewardene, R. O. Ball, and P. B. Pencharz Leucine Is Not a Good Choice as an Indicator Amino Acid for Determining Amino Acid Requirements in Men J. Nutr., April 1, 2006; 136(4): 958 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Mager, L. J. Wykes, E. A. Roberts, R. O. Ball, and P. B. Pencharz Mild-to-Moderate Chronic Cholestatic Liver Disease Increases Leucine Oxidation in Children J. Nutr., April 1, 2006; 136(4): 965 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kobayashi, H. Kato, Y. Hirabayashi, H. Murakami, and H. Suzuki Modulations of Muscle Protein Metabolism by Branched-Chain Amino Acids in Normal and Muscle-Atrophying Rats J. Nutr., January 1, 2006; 136(1): 234S - 236S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Layman and D. A. Walker Potential Importance of Leucine in Treatment of Obesity and the Metabolic Syndrome J. Nutr., January 1, 2006; 136(1): 319S - 323S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gleeson Interrelationship between Physical Activity and Branched-Chain Amino Acids J. Nutr., June 1, 2005; 135(6): 1591S - 1595S. [Abstract] [Full Text] [PDF] |
||||